ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
April 22, 2024 08:00 ET
|
Elevai Labs Inc.
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
April 22, 2024 07:30 ET
|
Lexeo Therapeutics
Lexeo Therapeutics gains intellectual property rights including current and future clinical data from ongoing Weill Cornell Medicine investigator-initiated trial of gene therapy candidate AAVrh.10hFXN...
Adeia Enters into IP License Agreement with Magenta Telekom
April 18, 2024 08:30 ET
|
Adeia Inc.
SAN JOSE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) ("Adeia" or the "Company"), the company whose patented innovations shape the way the world explores and experiences...
Horizon Group Inspires Creativity Through Partnerships with Top Brands
April 15, 2024 09:00 ET
|
Horizon Group USA
WARREN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Horizon Group USA, a leading global provider of innovative activity products, continues to keep creativity fun and accessible for families by...
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
April 11, 2024 07:00 ET
|
Arvinas Inc.
– Arvinas to receive a $150 million upfront payment for the license of ARV-766 and the sale of Arvinas’ preclinical AR-V7 program, with the potential under the License Agreement for up to $1.01...
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
April 10, 2024 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Northann Corp Announces Cross-Licensing Agreement with I4F for Digital Printing Technology
April 10, 2024 08:00 ET
|
Northann Corp.
ELK GROVE, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Northann Corp. (NYSE American: NCL), a leading innovator in 3D-printed home improvement solutions, is pleased to announce a strategic...
Thorium-HALEU based ANEEL™ fuel completes Pre-Licensing Milestone with Canadian Nuclear Safety Commission
April 09, 2024 08:12 ET
|
Clean Core Thorium Energy
Clean Core announced successful completion of the Phase 1 pre-licensing VDR process with CNSC, the regulatory authority for CANDU reactors.
UMeWorld to Debut the World's First & Only Weight Loss Cooking Oil in the US
April 09, 2024 08:00 ET
|
UMeWorld Limited
MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is excited to announce that the company has secured an exclusive license to use proprietary enzymatic technologies to...
Procleix ArboPlex Assay® di Grifols, primo e unico test NAT 4-in-1 per lo screening degli arbovirus, riceve il marchio CE
April 04, 2024 04:00 ET
|
Grifols, S.A.
Il test NAT in vitro di Grifols rileva quattro tipi di arbovirus, contribuendo a ridurre il rischio di infezioni trasmesse tramite trasfusioneGli arbovirus sono una minaccia emergente in crescita,...